Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 237

1.

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research.

Potter VT, Iacobelli S, van Biezen A, Maertens J, Bourhis JH, Passweg JR, Yakhoub-Agha I, Tabrizi R, Bay JO, Chevallier P, Chalandon Y, Huynh A, Cahn JY, Ljungman P, Craddock C, Lenhoff S, Russell NH, Fegueux N, Socié G, Benedetto B, Meijer E, Mufti GJ, de Witte T, Robin M, Kröger N.

Biol Blood Marrow Transplant. 2016 Jun 3. pii: S1083-8791(16)30118-5. doi: 10.1016/j.bbmt.2016.05.026. [Epub ahead of print]

PMID:
27264633
2.

Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.

Styczynski J, Tridello G, Gil L, Ljungman P, Hoek J, Iacobelli S, Ward KN, Cordonnier C, Einsele H, Socie G, Milpied N, Veelken H, Chevallier P, Yakoub-Agha I, Maertens J, Blaise D, Cornelissen J, Michallet M, Daguindau E, Petersen E, Passweg J, Greinix H, Duarte RF, Kröger N, Dreger P, Mohty M, Nagler A, Cesaro S.

J Clin Oncol. 2016 Jul 1;34(19):2212-20. doi: 10.1200/JCO.2015.64.2405. Epub 2016 Apr 18.

3.

Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.

Vanstraelen K, Prattes J, Maertens J, Lagrou K, Schoemans H, Peersman N, Vermeersch P, Theunissen K, Mols R, Augustijns P, Annaert P, Hoenigl M, Spriet I.

Eur J Clin Pharmacol. 2016 Apr 11. [Epub ahead of print]

PMID:
27066958
4.

Development, preliminary usability and accuracy testing of the EBMT 'eGVHD App' to support GvHD assessment according to NIH criteria-a proof of concept.

Schoemans H, Goris K, Durm RV, Vanhoof J, Wolff D, Greinix H, Pavletic S, Lee SJ, Maertens J, Geest SD, Dobbels F, Duarte RF.

Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.26. [Epub ahead of print]

PMID:
27042834
5.

High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Czerw T, Labopin M, Schmid C, Cornelissen JJ, Chevallier P, Blaise D, Kuball J, Vigouroux S, Garban F, Lioure B, Fegueux N, Clement L, Sandstedt A, Maertens J, Guillerm G, Bordessoule D, Mohty M, Nagler A.

Oncotarget. 2016 Mar 29. doi: 10.18632/oncotarget.8463. [Epub ahead of print]

6.

Longitudinal, in vivo assessment of invasive pulmonary aspergillosis in mice by computed tomography and magnetic resonance imaging.

Poelmans J, Hillen A, Vanherp L, Govaerts K, Maertens J, Dresselaers T, Himmelreich U, Lagrou K, Vande Velde G.

Lab Invest. 2016 Jun;96(6):692-704. doi: 10.1038/labinvest.2016.45. Epub 2016 Mar 28.

PMID:
27019389
7.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JA, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJ; VITAL and FungiScope Mucormycosis Investigators.

Lancet Infect Dis. 2016 Jul;16(7):828-37. doi: 10.1016/S1473-3099(16)00071-2. Epub 2016 Mar 9.

PMID:
26969258
8.

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long term disease control. An analysis from the Lymphoma Working Party Of the EBMT.

Robinson SP, Boumendil A, Finel H, Schouten H, Ehninger G, Maertens J, Crawley C, Rambaldi A, Russell N, Anders W, Blaise D, Yakoub-Agha I, Ganser A, Castagna L, Volin L, Cahn JY, Montoto S, Dreger P.

Ann Oncol. 2016 Mar 8. pii: mdw124. [Epub ahead of print]

PMID:
26961149
9.

Mucorales-Specific T Cells in Patients with Hematologic Malignancies.

Potenza L, Vallerini D, Barozzi P, Riva G, Gilioli A, Forghieri F, Candoni A, Cesaro S, Quadrelli C, Maertens J, Rossi G, Morselli M, Codeluppi M, Mussini C, Colaci E, Messerotti A, Paolini A, Maccaferri M, Fantuzzi V, Del Giovane C, Stefani A, Morandi U, Maffei R, Marasca R, Narni F, Fanin R, Comoli P, Romani L, Beauvais A, Viale PL, Latgè JP, Lewis RE, Luppi M.

PLoS One. 2016 Feb 12;11(2):e0149108. doi: 10.1371/journal.pone.0149108. eCollection 2016.

10.

Pretreatment of Bronchoalveolar Lavage Fluid Samples with SLsolution Leads to False-Negative Aspergillus Galactomannan Levels.

Gils S, Maertens J, Lagrou K.

J Clin Microbiol. 2016 Apr;54(4):1171. doi: 10.1128/JCM.02968-15. Epub 2016 Jan 13. No abstract available.

PMID:
26763955
11.

Plasmalyte: No Longer a Culprit in Causing False-Positive Galactomannan Test Results.

Spriet I, Lagrou K, Maertens J, Willems L, Wilmer A, Wauters J.

J Clin Microbiol. 2016 Mar;54(3):795-7. doi: 10.1128/JCM.02813-15. Epub 2015 Dec 30.

PMID:
26719444
12.

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis.

Versluis J, Hazenberg CL, Passweg JR, van Putten WL, Maertens J, Biemond BJ, Theobald M, Graux C, Kuball J, Schouten HC, Pabst T, Löwenberg B, Ossenkoppele G, Vellenga E, Cornelissen JJ; HOVON and SAKK Leukemia Groups.

Lancet Haematol. 2015 Oct;2(10):e427-36. doi: 10.1016/S2352-3026(15)00148-9. Epub 2015 Sep 18.

PMID:
26686044
13.

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ.

Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.

PMID:
26684607
14.

Diagnostic Performance of Galactomannan Antigen Testing in Cerebrospinal Fluid.

Chong GM, Maertens JA, Lagrou K, Driessen GJ, Cornelissen JJ, Rijnders BJ.

J Clin Microbiol. 2016 Feb;54(2):428-31. doi: 10.1128/JCM.02913-15. Epub 2015 Dec 9.

PMID:
26659218
15.

Characteristics of users of a tailored, interactive website for parents and its impact on adolescent vaccination attitudes and uptake.

Dempsey AF, Maertens J, Beaty B, O'Leary ST.

BMC Res Notes. 2015 Dec 1;8:739. doi: 10.1186/s13104-015-1721-8.

16.

Putting RNA to work: Translating RNA fundamentals into biotechnological engineering practice.

Peters G, Coussement P, Maertens J, Lammertyn J, De Mey M.

Biotechnol Adv. 2015 Dec;33(8):1829-44. doi: 10.1016/j.biotechadv.2015.10.011. Epub 2015 Oct 26. Review.

PMID:
26514597
17.

Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties.

Penack O, Tridello G, Hoek J, Socié G, Blaise D, Passweg J, Chevallier P, Craddock C, Milpied N, Veelken H, Maertens J, Ljungman P, Cornelissen J, Thiebaut-Bertrand A, Lioure B, Michallet M, Iacobelli S, Nagler A, Mohty M, Cesaro S.

Bone Marrow Transplant. 2016 Mar;51(3):418-23. doi: 10.1038/bmt.2015.237. Epub 2015 Oct 26.

PMID:
26501769
18.

Burden of serious fungal infections in Belgium.

Lagrou K, Maertens J, Van Even E, Denning DW.

Mycoses. 2015 Oct;58 Suppl 5:1-5. doi: 10.1111/myc.12389.

PMID:
26449500
19.

Comparative fluxome and metabolome analysis for overproduction of succinate in Escherichia coli.

Taymaz-Nikerel H, De Mey M, Baart GJ, Maertens J, Foulquié-Moreno MR, Charlier D, Heijnen JJ, van Gulik WM.

Biotechnol Bioeng. 2016 Apr;113(4):817-29. doi: 10.1002/bit.25850. Epub 2015 Oct 18.

PMID:
26444867
20.

Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

Cruciani M, Mengoli C, Loeffler J, Donnelly P, Barnes R, Jones BL, Klingspor L, Morton O, Maertens J.

Cochrane Database Syst Rev. 2015 Oct 1;(10):CD009551. doi: 10.1002/14651858.CD009551.pub3. Review.

PMID:
26424726
Items per page

Supplemental Content

Loading ...
Write to the Help Desk